These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 9269989

  • 1. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells.
    Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R, Greil R.
    Cancer Res; 1997 Aug 15; 57(16):3331-4. PubMed ID: 9269989
    [Abstract] [Full Text] [Related]

  • 2. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
    Mitsiades N, Yu WH, Poulaki V, Tsokos M, Stamenkovic I.
    Cancer Res; 2001 Jan 15; 61(2):577-81. PubMed ID: 11212252
    [Abstract] [Full Text] [Related]

  • 3. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line.
    Spierings DC, de Vries EG, Vellenga E, de Jong S.
    Cell Death Differ; 2003 Jul 15; 10(7):808-22. PubMed ID: 12815464
    [Abstract] [Full Text] [Related]

  • 4. p53-mediated up-regulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumor cells.
    Ruiz-Ruiz MC, López-Rivas A.
    Cell Death Differ; 1999 Mar 15; 6(3):271-80. PubMed ID: 10200578
    [Abstract] [Full Text] [Related]

  • 5. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
    Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM.
    Cancer Res; 1997 Sep 01; 57(17):3823-9. PubMed ID: 9288794
    [Abstract] [Full Text] [Related]

  • 6. Induction of Fas expression and augmentation of Fas/Fas ligand-mediated apoptosis by the synthetic retinoid CD437 in human lung cancer cells.
    Sun SY, Yue P, Hong WK, Lotan R.
    Cancer Res; 2000 Nov 15; 60(22):6537-43. PubMed ID: 11103825
    [Abstract] [Full Text] [Related]

  • 7. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec 15; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 8. Fas-dependent and -independent mechanisms of cell death following DNA damage in human colon carcinoma cells.
    Petak I, Tillman DM, Harwood FG, Mihalik R, Houghton JA.
    Cancer Res; 2000 May 15; 60(10):2643-50. PubMed ID: 10825136
    [Abstract] [Full Text] [Related]

  • 9. Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells.
    Brás A, Albar JP, Leonardo E, de Buitrago GG, Martínez-A C.
    Cell Death Differ; 2000 Mar 15; 7(3):262-71. PubMed ID: 10745271
    [Abstract] [Full Text] [Related]

  • 10. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M, Dusonchet L, Meli M, Grimaudo S, D'Alessandro N, Papoff G, Ruberti G, Rausa L.
    Cell Death Differ; 1998 Sep 15; 5(9):735-42. PubMed ID: 10200532
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vitro prevention of cell-mediated xeno-graft rejection via the Fas/FasL-pathway in CrmA-transducted porcine kidney cells.
    Fujino M, Li XK, Suda T, Hashimoto M, Okabe K, Yaginuma H, Mikoshiba K, Guo L, Okuyama T, Enosawa S, Amemiya H, Amano T, Suzuki S.
    Xenotransplantation; 2001 May 15; 8(2):115-24. PubMed ID: 11328582
    [Abstract] [Full Text] [Related]

  • 15. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.
    Xu X, Fu XY, Plate J, Chong AS.
    Cancer Res; 1998 Jul 01; 58(13):2832-7. PubMed ID: 9661898
    [Abstract] [Full Text] [Related]

  • 16. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand.
    Zipp F, Martin R, Lichtenfels R, Roth W, Dichgans J, Krammer PH, Weller M.
    J Immunol; 1997 Sep 01; 159(5):2108-15. PubMed ID: 9278296
    [Abstract] [Full Text] [Related]

  • 17. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
    Juang SH, Pan WY, Kuo CC, Liou JP, Hung YM, Chen LT, Hsieh HP, Chang JY.
    Biochem Pharmacol; 2004 Jul 15; 68(2):293-303. PubMed ID: 15194001
    [Abstract] [Full Text] [Related]

  • 18. Crosstalk between keratinocytes and T lymphocytes via Fas/Fas ligand interaction: modulation by cytokines.
    Arnold R, Seifert M, Asadullah K, Volk HD.
    J Immunol; 1999 Jun 15; 162(12):7140-7. PubMed ID: 10358159
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Critical roles for JNK, c-Jun, and Fas/FasL-Signaling in vitamin E analog-induced apoptosis in human prostate cancer cells.
    Jia L, Yu W, Wang P, Li J, Sanders BG, Kline K.
    Prostate; 2008 Mar 01; 68(4):427-41. PubMed ID: 18196534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.